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In Brief
Assmann et al. examine the molecular
mechanism underlying a recently
described Fanconi syndrome.
Mistargeting of the peroxisomal protein
EHHADH to mitochondria leads to
impaired mitochondrial fatty acid
b-oxidation and respiration, resulting in
decreased ATP production. Diminished
transport activity leads to the observed
Fanconi syndrome.
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We recently reported an autosomal dominant form of
renal Fanconi syndrome caused by amissensemuta-
tion in the third codon of the peroxisomal protein
EHHADH. The mutation mistargets EHHADH to mito-
chondria, thereby impairing mitochondrial energy
production and, consequently, reabsorption of elec-
trolytes and low-molecular-weight nutrients in the
proximal tubule. Here, we further elucidate the mo-
lecular mechanism underlying this pathology. We
find that mutated EHHADH is incorporated into mito-
chondrial trifunctional protein (MTP), thereby dis-
turbing b-oxidation of long-chain fatty acids. The
resulting MTP deficiency leads to a characteristic
accumulation of hydroxyacyl- and acylcarnitines.
Mutated EHHADH also limits respiratory complex I
and corresponding supercomplex formation, leading
to decreases in oxidative phosphorylation capac-
ity, mitochondrial membrane potential maintenance,
and ATP generation. Activity of the Na+/K+-ATPase is
thereby diminished, ultimately decreasing the trans-
port activity of the proximal tubule cells.
INTRODUCTION
Fanconi syndrome is a disorder of the proximal kidney tubule. It
is characterized by failure of the proximal tubule to reabsorb
filtered molecules, causing urinary loss of amino acids, glucose,
electrolytes, phosphate, and low-molecular-weight proteins.
Klootwijk et al. (2014) recently described a new form of inherited
Fanconi syndrome caused by mutation of the EHHADH gene,
which is highly expressed in human liver and kidney (Hoefler
et al., 1994). EHHADH (enoyl-coenzyme A hydratase/L-3-hy-
droxyacyl-coenzyme A dehydrogenase) is a peroxisomal protein
involved in b-oxidation of fatty acids. Mutation at p.E3K results inCel
This is an open access article unda de novomitochondrial import sequence, resulting in mistarget-
ing to mitochondria. The mutated protein interferes with mito-
chondrial energy production, which is predominantly based on
fatty acid oxidation (FAO) in proximal tubular cells, leading to
Fanconi syndrome.
Peroxisomes are the site of initial b-oxidation for very-long-
chain and branched-chain fatty acids. In contrast, long-chain
fatty acids, constituting the main source of energy under physio-
logical conditions (Reddy and Hashimoto, 2001), are oxidized
in the mitochondria by the mitochondrial trifunctional protein
(MTP). The MTP is a hetero-octamer composed of four a and
four b subunits and is bound to the inner mitochondrial mem-
brane. Thea subunit (HADHA) catalyzes the first steps ofb-oxida-
tion (hydration and dehydrogenation), whereas the b subunit
(HADHB) facilitates the thiolytic cleavage step.
Mitochondrial FAO disruption leads to export of acylcarnitines
to the extracellular fluid (Ventura et al., 1998; Violante et al.,
2013). Consequently, plasma acylcarnitine levels are currently
a key biomarker for neonatal screening of mitochondrial FAO
disorders (Rinaldo et al., 2008).
Reducing equivalents, which are formed during the b-oxida-
tion cycle, are fed into mitochondrial oxidative phosphorylation,
and it has been shown that accumulation of b-oxidation interme-
diates impairs and possibly uncouples mitochondrial oxidative
phosphorylation (Ho and Pande, 1974; Shrago et al., 1995;
Ventura et al., 1995, 1996; Tonin et al., 2013). Mitochondrial
supercomplexes, wherein the respiratory chain complexes I, III,
and IV associate with each other in varying ratios, are also known
to interact with FAO complexes (Wang et al., 2010). These super-
complexes mediate direct electron transfer and thus more
efficient oxidative phosphorylation. Mitochondrial fatty acid
b-oxidation and oxidative phosphorylation are therefore tightly
coupled processes.
The transport activity of the proximal tubule is highly depen-
dent on ATP to supply sufficient energy for Na+/K+-ATPase
to build up the electrochemical gradient (Balaban et al., 1980),
which drives resorption of solutes from the primary urine in
the proximal tubule (Curthoys and Moe, 2014). This paper,l Reports 15, 1423–1429, May 17, 2016 ª 2016 The Author(s) 1423
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Mislocalization of EHHADHMUT and Effect on FAO
(A) Immunoblot analysis of total cell lysate against EHHADH shows an additional band 2.5 kDa lower in molecular mass in EHHADHMUT cells, indicating an
N-terminal truncation upon import into mitochondria.
(B) Immunoblot analysis of purified mitochondria against EHHADH. Mitochondrial localization of the truncated but not the full-length EHHADHMUT is shown by
immunoblot analysis of purified mitochondria, whereas EHHADHWT is not imported into mitochondria.
(C) In the BN-PAGE-immunoblot against EHHADH, a band is observed at500 kDa in EHHADHMUT cells, corresponding to the expected mass of the native MTP
complex, indicating the interaction of EHHADHMUT with the MTP complex. In contrast, no band is observed for EHHADHWT cells.
(D) BN-PAGE-immunoblot analysis against HADHB shows a band at the expected 500 kDa in both EHHADHMUT and EHHADHWT cells, pointing toward an
exchange of EHHADHMUT for the a subunit.
(E) Increased amounts of long-chain acylcarnitines were found in EHHADHMUT cells compared with EHHADHWT cells, indicating abnormal b-oxidation of long-
chain fatty acids (n = 4). n.d., not detected.
(F) Decreased palmitic acid uptake rate in EHHADHMUT cells (n = 4).
(G) Decreased amount of 1,2-13C-labeled acetyl-coenzyme A derived from FAO in EHHADHMUT compared with EHHADHWT cells (n = 3).
(H) Diminished amount of 13CO2 produced by the EHHADHMUT cell line (n = 3).
Values are mean ± SEM. *p% 0.05, ***p% 0.001.employing a combination of cell biological, biochemical, pro-
teomic, and metabolomic methods, aims to elucidate how
mitochondrial mislocalization of EHHADH leads to Fanconi
syndrome.
RESULTS
Subcellular Localization of Mutated EHHADH
The p.E3K-mutation of EHHADHMUT leads to the generation of
an N-terminal mitochondrial targeting sequence in addition to
the native C-terminal peroxisomal targeting sequence (Kloot-
wijk et al., 2014). Therefore, EHHADHMUT localizes to both
peroxisomes and mitochondria. Upon import into mitochondria,
the mitochondrial targeting sequence is cleaved, resulting in an
N-terminally truncated form of EHHADH, as evidenced by anti-
EHHADH immunoblot analysis (Figure 1A), which shows an
additional band for the EHHADHMUT cells. Consequently, only
the truncated form is observed in an immunoblot of isolated
mitochondria from EHHADHMUT cells, whereas only a faint1424 Cell Reports 15, 1423–1429, May 17, 2016band is observed for mitochondria of the EHHADH wild-
type (EHHADHWT) cells (Figure 1B), presumably caused by
minor mislocalization of overexpressed EHHADHWT. Respec-
tive loading controls using marker proteins are shown in
Figure S1.
Interaction Analysis of Mislocalized EHHADHMUT in
Mitochondria
Co-immunoprecipitation against EHHADH from purified mito-
chondria and subsequent GeLC-MS/MS identified HADHA and
HADHB, both subunits of the MTP complex, as potential inter-
action partners, confirming our previous co-immunoprecipita-
tion results using an HADHB antibody (Klootwijk et al., 2014).
To investigate this interaction in more detail, a blue native
(BN) PAGE of mitochondrial protein complexes isolated from
EHHADHMUT and EHHADHWT cells with subsequent immu-
noblotting against EHHADH and HADHB was performed. In
EHHADHMUT cells, a band was observed at 500 kDa, corre-
sponding to the native MTP complex, indicating the interaction
Figure 2. Cellular Energy Supply and Transport Activity
(A) The cellular ATP level is significantly reduced in EHHADHMUT cells (n = 4).
(B) The activity of Na+/K+-ATPase generating the driving force for transcellular transport is significantly diminished (n = 5).
(C–E) The transcellular transport of all tested solutes within 8 hr (C, 18O-phosphate; D, 13C6-lysine; E, Gly-Sar-dipeptide) is reduced by more than 90% in
EHHADHMUT cells. The values for
18O-phosphate were below the lower limit of quantification (LLOQ, indicated by the dotted line) for EHHADHMUT cells (n = 6).
Values are mean ± SEM. *p% 0.05, **p% 0.01.of EHHADHMUT with the MTP complex. In contrast, no band was
observed for EHHADHWT cells (Figure 1C). Moreover, the band
for HADHB was found at the expected 500 kDa in both
EHHADHWT and EHHADHMUT cells (Figure 1D). No mass shift
was observed in the BNPAGE immunoblot against HADHB, sug-
gesting replacement of one or more a subunits (79 kDa) of the
MTP complex with EHHADHMUT (77 kDa), which are of similar
molecular mass, rather than replacement of much smaller b sub-
units (51 kDa) or additional attachment of EHHADHMUT to the
MTP complex.
Metabolic Analysis
Accumulation of acylcarnitines and hydroxyacylcarnitines
because of impaired b-oxidation is a diagnostic marker of MTP
deficiencies. The amounts of tetradecanoyl- and hexadecanoyl-
carnitine as well as their corresponding ketoacyl- and hy-
droxyacylcarnitines were significantly elevated in EHHADHMUT
cells. The concentration of hydroxyhexadecanoylcarnitine in
EHHADHWT cells was even below the detection limit (Figure 1E).
The reduced FAO, in turn, leads to significantly reduced uptake
of fatty acids from the medium (Figure 1F; p = 0.016; Eaton,
2002; Hirschey et al., 2010). Also, the level of FAO-derived
acetyl-coenzyme A (CoA) was lower in EHHADHMUT than in
EHHADHWT cells (Figure 1G; p = 0.044) using U-
13C-labeled pal-
mitic acid as the primary energy source. This finding is further
corroborated by a significant decrease in 13CO2-production by
EHHADHMUT cells (Figure 1H; p = 4.4 3 10
5). Consequently,
a significant 45% reduction in ATP content was found in
EHHADHMUT cells (Figure 2A; p = 0.012), indicating a reduced
energy supply. Markedly, the decrease in ATP level in the
EHHADHMUT cells did not result in a significant increase in
apoptosis within the 7-day stimulation period (data not shown).
However, extending the expression of mutated EHHADH for 3
more days resulted in a significant increase in the fraction of
apoptotic EHHADHMUT cells compared with EHHADHWT cells
(Figure S2; p = 4.6 3 108).Activity of Na+/K+-ATPase and Diminished Transcellular
Transport
Uptake of Rb+, as a surrogate substrate for Na+/K+-ATPase, was
measured by inductively coupled plasma-optical emission spe-
troscopy (ICP-OES). The activity of Na+/K+-ATPase was signifi-
cantly reduced in the EHHADHMUT cell line (Figure 2B; p =
0.023). As a consequence, the transcellular transport of phos-
phate (p = 0.005), lysine (p = 0.002), and the dipeptide Gly-Sar
(p = 0.002) in EHHADHMUT cells was reduced more than 20-
fold compared with EHHADHWT cells (Figures 2C and 2D).
High-Resolution Respirometry and Confocal
Microscopy
High-resolution respirometry revealed a significantly reduced
oxidative phosphorylation capacity of EHHADHMUT cells after
addition of palmitoylcarnitine andmalate (electron transfer flavo-
protein [ETF]OXPHOS) as substrates for b-oxidation. The respec-
tive results are shown in Figure 3A, top. Addition of substrates
for complex I (CIOXPHOS) resulted in no further increase in oxygen
consumption, with EHHADHMUT cells still showing decreased
oxygen consumption. After addition of substrate for complex II
(CI+II+ETFOXPHOS) and at maximum oxidative phosphorylation
in a coupled state, EHHADHMUT cells showed significantly
reduced oxidative phosphorylation, and the oxygen consump-
tion linked to ATP (O2-ATP CI+II+ETF) was reduced by 22%.
After uncoupling, respiration rose similarly,0.06 pmol/(s*ml*ci-
trate synthase unit) in both EHHADHWT and EHHADHMUT cells,
and the latter still showed decreased respiration, indicating
that not only the oxidative phosphorylation machinery but also
the electron transport system were impaired. After inhibition of
complex I (CII ETS), the uncoupled complex II respiration was
still significantly reduced in EHHADHMUT cells. Remarkably,
use of octanoyl- instead of palmitoylcarnitine did not result in a
substantial change of the results (Figure 3A, bottom). In concor-
dance with the reduced respiratory activity of the EHHADHMUT
cells, the mitochondrial membrane potential was reducedCell Reports 15, 1423–1429, May 17, 2016 1425
Figure 3. Results of High-Resolution Respi-
rometry Analysis, Confocal Microscopy,
and BN PAGE
(A) Significantly reduced respiration in EHHADHMUT
cells after the addition of substrates for ETF
(top, palmitoylcarnitine; bottom, octanoylcarni-
tine), complex I, and complex II compared with
EHHADHWT cells. After inhibition of ATP synthase
(LEAK) and uncoupling (ETS and CII ETS),
EHHADHMUT cells show significantly reduced
levels of respiration, indicating a dysfunction in
both the phosphorylation and non-phosphoryla-
tion part of the respiratory chain. Use of octa-
noylcarnitine instead of the typical MTP substrate
palmitoylcarnitine did not result in enhanced
mitochondrial respiration. Values are mean ±
SEM, normalized to citrate synthase (CS) activity
(n = 10).
(B) The mitochondrial membrane potential (Dcm),
measured by tetramethylrhodamine, was signifi-
cantly greater in EHHADHWT than in EHHADHMUT
cells (top left). ROS production, measured with
the mitochondrially targeted superoxide probe
MitoSOX, was significantly higher in EHHADHWT
cells (top right), whereas glutathione levels,
measured using monochlorobimane, were signifi-
cantly higher in EHHADHMUT cells (bottom left). No significant difference was found in mitochondrial NAD(P)H signal (bottom right).
(C) Immunoblot analysis against EHHADH in mitochondrial complexes separated by 2D BN/SDS-PAGE. Incorporation of mutated EHHADH into the respiratory
chain complex I (CI), supercomplexes (SC), and solitary MTPs) is demonstrated.
(D) Exemplary BN PAGE of mitochondria isolated from EHHADHWT and EHHADHMUT cells, respectively, stained with lava purple for quantification (top).
Densitometric analysis of supercomplex assembly in EHHADHWT and EHHADHMUT cells (bottom) reveals a reduced level of supercomplex assembly in the latter.
Values are mean ± SEM, normalized to complex V (n = 7).
*p % 0.05, **p % 0.01, ***p % 0.001.(Figure 3B, top left). Consequently, the generation of mitochon-
drial reactive oxygen species (ROS) was reduced (Figure 3B,
top right), and glutathione levels were higher in the EHHADHMUT
cells (Figure 3B, bottom left). Therefore, no signs of increased
oxidative stress were obtained in the mutant, and no change in
themitochondrial nicotinamide adenine dinucleotide(phosphate)
(NAD(P)H) signal was observed in confocal microscopy (Fig-
ure 3B, bottom right).
Differential Proteomic Analysis of Whole-Cell Lysates
The differential proteomic analysis by sequential window acqui-
sition of all theoretical fragment-ion spectra (SWATH)-MS re-
vealed significant downregulation of several constituents of
complex I of the respiratory chain (six of the nine identified sub-
units are significantly downregulated; Table S3). All other respi-
ratory chain complexes showed either no regulation or no clear
trend in regulation. Furthermore, several proteins involved in
fatty acid b-oxidation were significantly regulated, including
peroxisomal bifunctional enzyme isoform 1 (EHHADH) and
acyl-CoA binding protein, which were significantly upregulated
in EHHADHMUT cells.
Respiratory Supercomplex Assembly
2D BN/SDS-PAGE immunoblot analysis against EHHADH in
EHHADHMUT cells showed an association of mutated EHHADH
with respiratory complexes, whereas no association was visible
in EHHADHWT cells (Figure 3C). Furthermore, incorporation of
mutated EHHADH into the solitary MTP complex, indicated by1426 Cell Reports 15, 1423–1429, May 17, 2016a band at the expected height of 500 kDa, is once again
observed (see also Figure 1D). Densitometric analysis of the
BN PAGE showed that EHHADHMUT cells contained markedly
less supercomplex than EHHADHWT cells (Figure 3D; p = 0.009).
DISCUSSION
This paper aimed to elucidate the molecular consequences of
the mistargeting of the peroxisomal protein EHHADH into mito-
chondria, causing an isolated autosomal dominant Fanconi’s
syndrome.
Mislocalization to the mitochondria and truncation of
EHHADHMUT by the mitochondrial import machinery was shown
by means of immunoblot analysis of isolated mitochondria.
Moreover, the mutated untruncated form is still localized to its
genuine compartment, the peroxisome; thus, peroxisomal FAO
presumably remains unaffected. This is in concordance with
our previous report showing that the p.E3K mutation results
in a de novo mitochondrial import sequence that mistargets
EHHADHMUT into mitochondria, and no indications of distur-
bance of the peroxisomal FAO in the patients were obtained
(Klootwijk et al., 2014). Furthermore, EHHADHMUT was found
to associate with MTP. The absence of a mobility shift in BN
PAGE between native MTP and EHHADHMUT containing MTP
suggests the incorporation of EHHADHMUT into MTP, likely in
exchange for an original a subunit, instead of mere attachment
to the hetero-octameric complex or exchange of a much smaller
b subunit.
Incorporation of mislocalized EHHADHMUT into MTP leads to
impaired b-oxidation of long-chain fatty acids, causing, in turn,
increased levels of long-chain acylcarnitines, which is a well-
known clinical parameter for FAO disorders (Rinaldo et al.,
2008). The acylcarnitine profile of EHHADHMUT cells showed
an increase in long-chain 2-enoyl-, hydroxy-acyl-, and acylcarni-
tines, resembling the situation in patients with long chain
3-hydroxyacyl-CoA dehydrogenase (LCHAD) or MTP deficiency
(Sander et al., 2005). This lends further support to an impaired
b-oxidation of long-chain fatty acids by incorporation of
EHHADHMUT into the MTP.
The major source for energy generation in proximal tubular
cells is oxidative metabolism, mostly from fatty acids (Epstein,
1997). Beck et al. (1991) showed a decrease in the intracellular
ATP level after stimulation of sodium transport in isolated rabbit
proximal convolute tubules, indicating that physiological ATP
levels in proximal tubular cells barely suffice to meet cellular
energy demands. Although the levels of intracellular ATP in
EHHADHWT cells agree with published data (Andreoli and Mal-
lett, 1997; Balaban et al., 1980; Migita et al., 2007), EHHADHMUT
cells showed a marked decrease in intracellular ATP level. This
decrease also fits the concept of disturbed b-oxidation because
of the mistargeting of EHHADHMUT into mitochondria.
Disturbance of b-oxidation will also affect the uptake of fatty
acids and production of acetyl-CoA as the end product of
b-oxidation. We observed a decreased uptake in EHHADHMUT
cells. Furthermore, an increase in long-chain acylcarnitines leads
to export from mitochondria instead of an import of long-chain
acyl-CoAs. In SWATH-MS analysis, an increased amount of
acyl-CoA binding protein was found. This could be due to an in-
crease in long-chain acyl-CoAs in the cytosol of EHHADHMUT
cells counteracting the higher cytosolic long-chain acyl-CoA
concentration.More probable is that lack of ATP impairs the acti-
vation of imported fatty acids to form long-chain acyl-CoAs (Ea-
ton, 2002) and, thereby, lowers the uptake of long-chain fatty
acids. Taken together, the accumulation of intermediates of
b-oxidation leads to product inhibition and, thereby, decreases
both mitochondrial b-oxidation flux and the amount of acetyl-
CoA, CO2, and, consequently, ATP produced by degradation
of fatty acids.
The mitochondrial respiratory chain and mitochondrial
b-oxidation are tightly coupled processes. A physical associa-
tion betweenmitochondrial fatty acid b-oxidation and respiratory
chain complexes via MTP was shown by Wang et al. (2010). The
mistargeting of EHHADHMUT into mitochondria leads to its
incorporation into MTP and subsequent incorporation into
the respiratory supercomplexes, as shown by immunoblot anal-
ysis of 2D BN/SDS-PAGE (Figure 3C). Supercomplex assembly
in EHHADHMUT cells was decreased compared with that in
EHHADHWT cells. Therefore, the erroneous incorporation of
mutated EHHADH into MTP might lead to a conformational
change in the fatty acid b-oxidation complex and, thus, to an
impaired supercomplex assembly, resulting in degradation of
individual subunits, as indicated by the decrease in abundance
of several subunits of complex I of the respiratory chain. The for-
mation of supercomplexes in the mitochondrial inner membrane
features some functional advantages because it mediates
substrate channeling, increases electron transfer rates, showshigher catalytic efficiency, sequesters reactive intermediates,
and, in addition, stabilizes respiratory chain complexes (Scha¨g-
ger, 2001). Thus, a decrease in mitochondrial respirasome
assembly will lead to a decrease in oxidative phosphorylation
capacity, as shown by Rosca et al. (2008). We also observed a
decreased oxidative phosphorylation capacity in EHHADHMUT
cells. The dysfunction in the oxidative phosphorylation system
is located in both the phosphorylation and non-phosphorylation
system because the EHHADHMUT cells still showed decreased
oxygen consumption after inhibition of ATP synthase and un-
coupling. In patients with mere MTP deficiency, substitution
of dietary long-chain fat with medium-chain triglycerides will
alleviate clinical symptoms (Saudubray et al., 1999; Gillingham
et al., 2006) because medium-chain triglycerides can enter
mitochondria independently of carnitine and bypass the long-
chain b-oxidation enzymes. In contrast, the substitution of palmi-
toylcarnitine with octanoylcarnitine in respirometric analysis of
EHHADHMUT cells did not normalize but merely led to a less
pronounced decrease in respiratory activity (Figure 3A). There-
fore, the direct effects on assembly and activity of the respiratory
chain make a substantial contribution to the decrease in
ATP production in addition to the diminished FAO, which may,
at least in part, be compensated by other energy-producing
processes.
The production of ATP is essential for maintaining the
activity of Na+/K+-ATPase, which is responsible for generation
of the electrochemical gradient across the plasma mem-
brane, required for renal tubular reabsorption. Therefore, the
decreased ATP level in EHHADHMUT cells leads to lower activity
of Na+/K+-ATPase, as shown by uptake of Rb+ as a K+ surro-
gate. Consequently, transport of all tested solutes across prox-
imal tubular cells was drastically decreased, inducing Fanconi
syndrome and the clinical symptom of rickets caused by the
loss of phosphate. These findings are in accordance with the
previously published decrease in glucose transport activity
(Klootwijk et al., 2014). The fact that no other clinically relevant
symptoms are caused by EHHADH mislocalization is presum-
ably due to the particularly high expression of EHHADH in the
late proximal tubule and the high energy demand of the proximal
tubule cells, which is for the most part covered by FAO (Epstein,
1997).
Subsequent studies will be focused on physiological analyses
in vivo as conducted for other proximal tubular disorders; e.g.,
using a respective knockin mouse model (Novarino et al.,
2010) or primary cell culture (Gorvin et al., 2013; Ivanova et al.,
2015) if patient material is available.
Conclusions
Mistargeting of EHHADHMUT to mitochondria impairs mitochon-
drial fatty acid b-oxidation and respiration because of interaction
and interference with the mitochondrial trifunctional protein MTP
and the respiratory chain supercomplexes bymutated EHHADH.
This leads to decreased oxidative phosphorylation, an accumu-
lation of acylcarnitines, and decreased mitochondrial energy
production in proximal tubular cells, all of which contribute to
decreased reabsorption of electrolytes and low-molecular-
weight nutrients, a characteristic of renal Fanconi syndrome
(Figure 4).Cell Reports 15, 1423–1429, May 17, 2016 1427
Figure 4. Effect ofMistargeted EHHADHMUT
on Mitochondrial Function
The import of EHHADHMUT into mitochondria and
incorporation into the MTP complex leads to a
reduction of MTP activity and a decreased su-
percomplex assembly. Both result in reduced
oxidative phosphorylation, which decreases the
intracellular ATP level. This, in turn, decreases
proximal tubular transport and, consequently,
causes Fanconi syndrome (green/orange, up/
downregulation).EXPERIMENTAL PROCEDURES
LLC-PK1 cells stably transfected with either EHHADHWT or EHHADHMUT
cDNA using the Tet-On inducible gene expression system (Klootwijk et al.,
2014) were used for all studies, with 7 days of stimulation. Cells were harvested
by scraping in ice-cold methanol. In case of isolation of mitochondria by differ-
ential centrifugation and co-immunoprecipitation using protein A/G magnetic
beads, cells were harvested by trypsination. All metabolite analyses were
accomplished using GC- or LC-MS. ATP and apoptosis measurements were
conducted using commercially available kits. Mass spectrometrical protein
analyses for protein interactions and label-free, differential analysis were
done using nano-LC- quadrupole time of flight-MS. For analysis of Na+/K+-
ATPase activity, Rb+ was used as a K+ surrogate and measured by ICP-OES.
For respirometry, confocal microscopy, and detailedmethod descriptions, see
the Supplemental Experimental Procedures. Comparisons between groups1428 Cell Reports 15, 1423–1429, May 17, 2016were made using Student’s t tests. p% 0.05 was considered statistically sig-
nificant. In case of multiple testing, p values were adjusted by controlling the
false discovery rate (Benjamini and Hochberg, 1995). In all figures, *p %
0.05, **p% 0.01, and ***p% 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.04.037.
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